Profile

I work with intellectual property law and competition law, often for clients in the life sciences sector.

I have great experience of representing clients in disputes relating to patents and trademarks, in court and arbitral proceedings and with public authorities. In my daily work, I also help companies with issues relating to licences, research and development collaboration, public procurement and competition law and regulatory issues. I am used to managing and coordinating complex projects with international links.

Språk: English, Swedish, Swedish

Karriär

2002-

Setterwalls

2000-2001

McGill University

2002

Lund University, LL.M.

Rekommendationer

  • “Martin Levinsohn is an excellent lawyer.”

    Chambers & Partners

  • “Brings a wealth of expertise in parallel importing law, regulatory know-how, and the unitary patent.”

    IAM Patent

  • “With excellent courtroom acumen, he combines his deep legal and technical knowledge to develop compelling arguments.”

    IAM Patent

  • “Martin Levinsohn is the name to note.”

    Legal 500

  • “A trusted resource in and out of the courtroom, he effectively handles intricate disputes”

    World Trademark Review

  • “Martin is very responsive and technically able.”

    Chambers Europe

  • “Martin is very precise and available, and has excellent knowledge of local patent law practices.”

    Chambers Europe

  • “Martin is very responsive and technically able.”

    Chambers Europe

  • “Martin is very precise and available, and has excellent knowledge of local patent law practices.”

    Chambers Europe

  • “Martin is very precise and available, and has excellent knowledge of local patent law practices.”

    Chambers Global

  • “Martin Levinsohn is really strong in how he manages cases, smart and has a good commercial sense.”

    Chambers Global

  • “Unafraid to test the bounds of patent law. He is one of the most important Swedish practitioners in the generics and biosimilars space, and along with having a brilliant grasp of complex technical aspects, he can translate those into arguments that are both clear and concise.”

    IAM Patent (Gold)

  • “Instils confidence in clients with his ability to understand complex technical aspects and convert that into winning legal arguments.”

    IAM Patent 1000

  • “Martin Levinsohn – the captain of the ship with a steady hand on the helm. Significant representation of generic pharma clients in life sciences patents disputes.”

    Legal 500

  • “I'm very happy with Martin's services and trust his advice. He is calm, focused and delivers a great value-for-money input. He is not afraid to give ad-vice on commercial matters.”

    Chambers Global

  • “One of Sweden’s brightest lawyers, Martin is super innovative and finds brilliant new ways to tackle complicated matters. He is brilliant at grasping the technical aspects of a case and, most importantly, he is not afraid to push the boundaries of patent law.”

    IAM Patent

  • “A pragmatic lawyer who gives comprehensive advice.”

    Chambers Europe

  • “Extremely skilled litigator.”

    IAM Patent

  • “A fantastic and shrewd lawyer.”

    Chambers Global

  • “A pragmatic lawyer who gives comprehensive advice.”

    Chambers Global

  • “Quick replies, personable nature and great collaboration with expert witnesses.”

    IAM Patent

  • “The work of “extremely skilled litigator” Levinsohn is "always very thorough. His advice considers the business goals of his clients and the industries in which they operate".”

    IAM Patent

  • “Recommended without hesitation for pan-European tasks is Martin Levinsohn. Responsive and well prepared, his advice is practical and well balanced. In the courtroom, he delivers measured, deliberate arguments that get straight to the point.”

    IAM Patent

  • “a calm and collected attorney, he convincingly presents his cases to the court.”

    IAM Patent

  • “a good communicator with a sharp mind.”

    Legal 500

  • “Dedicated and very sharp.”

    Legal 500

  • “He is a very good communicator, and extremely knowledgeable about marketing issues.”

    Chambers

  • “Peers and clients regard Martin Levinsohn as "an extremely skilled lawyer." He is known for his patent and trade mark expertise relating to the pharma industry.”

    Chambers

  • “Intellectual Property – Martin Levinsohn is the ‘sharp, competent’ practice head.”

    Legal 500

  • “Martin Levihnson has deep knowledge and understanding of the pharma sector in Sweden”

    Legal 500

  • “Martin Levinsohn is really strong in how he manages cases, smart and has a good commercial sense.”

    Chambers Europe

  • “Martin Levinsohn and Karolina Jivebäck Pap: in addition to their outstanding knowledge of the sector and of local law, they have provided advice in a timely and clear manner, with strategic outlook and full discussion of the possible scenarios.”

    Legal 500

  • “Martin Levinsohn is a very good operator and well-known name in the IP/patents field.”

    Legal 500

Case

Case | 22 Dec 2025

Setterwalls has successfully represented Sandoz in a patent dispute regarding Xarelto® (rivaroxaban) in Sweden

Read more
Case | 03 Mar 2025

Setterwalls advised in connection with the Swedish Competition Authority’s investigation of suspected coordination of price levels on generic drugs

Read more
Case | 04 Sep 2024

Setterwalls advised client in patent dispute on rock drilling rigs

Read more
Case | 06 Jul 2023

Electric rock drilling rigs did not infringe patent

Read more
Case | 27 Jan 2023

Patent on playground swings was found invalid

Read more
Case | 11 Nov 2022

Setterwalls has successfully represented two pharmaceutical companies in defence against claims for preliminary injunctions

Read more
Case | 29 Aug 2022

No interim injunction before the patent is granted

Read more
Case | 19 Aug 2022

High requirements for ex parte injunctions under the Patent Act

Read more
Case | 26 Mar 2021

Setterwalls successfully represented Abboxia vs. the Medical Products Agency

Read more
Case | 13 Aug 2020

Setterwalls assisted Isofol when entering into a licensing agreement with Solasia

Read more
Case | 28 May 2020

The Court of Justice of the European Union confirms the reasoning that lead to Sandoz’ win in the Patent and Market Court of Appeal

Read more
Case | 02 Apr 2020

Setterwalls successfully represented Orifarm Generics in patent dispute

Read more
Case | 10 Feb 2020

Setterwalls has successfully represented Sandoz in a patent dispute in the Patent and Market Court.

Read more
Case | 31 Jan 2020

Setterwalls successfully acted for Teva in patent dispute at the Patent and Market Court of Appeal

Read more
Case | 09 Sep 2019

Parallel traders must rebox medicinal products bearing an anti-tampering device

Read more
Case | 20 Mar 2019

Setterwalls successfully represented Europrofil in dispute concerning alleged patent infringement

Read more
Case | 01 Feb 2019

Setterwalls successfully represented Sandoz in dispute over supplementary protection certificate for medicinal products

Read more
Case | 14 Aug 2018

Setterwalls successfully acted for Sandoz in patent dispute

Read more
Case | 18 Jun 2018

Setterwalls acted for Orifarm in parallel trade case

Read more
Case | 25 May 2018

Setterwalls acted for Teva in relation to revocation of pharmaceutical patent

Read more
Case | 14 Jun 2016

Setterwalls advisor in revocation of pharma patent

Read more
Case | 07 Oct 2015

Setterwalls assisted KLS Ugglarps in the acquisition of the majority shares in Dalsjöfors Kött

Read more
Case | 02 Sep 2014

Setterwalls' represented Apotek Hjärtat in procurement dispute

Read more

Artiklar

ADHD Drug Patent Held to Cover All Salt Forms
News | 22 May 2026

ADHD Drug Patent Held to Cover All Salt Forms

Läs nyhet
Sweden’s application of the IPI measure in relation to Chinese medical devices: almost one year on
News | 22 May 2026

Sweden’s application of the IPI measure in relation to Chinese medical devices: almost one year on

Läs nyhet
UPC Court of Appeal Refers Key Questions on Cross-Border Injunctions to CJEU
News | 13 Mar 2026

UPC Court of Appeal Refers Key Questions on Cross-Border Injunctions to CJEU

Läs nyhet
Long-Arm Jurisdiction and the Emerging Role of Anti-Suit Injunctions
News | 26 Feb 2026

Long-Arm Jurisdiction and the Emerging Role of Anti-Suit Injunctions

Läs nyhet
Setterwalls Receives Gold Ranking in World Trademark Review
News | 29 Jan 2026

Setterwalls Receives Gold Ranking in World Trademark Review

Läs nyhet
How UPC Preliminary Opinions could reshape Swedish patent litigation
News | 23 Oct 2025

How UPC Preliminary Opinions could reshape Swedish patent litigation

Läs nyhet
Setterwalls Gold ranked by the World Trademark Review
News | 05 Feb 2025

Setterwalls Gold ranked by the World Trademark Review

Läs nyhet
The Swedish and Danish Competition Authorities have carried out dawn raids at companies active in the pharmaceutical sector
News | 09 Sep 2024

The Swedish and Danish Competition Authorities have carried out dawn raids at companies active in the pharmaceutical sector

Läs nyhet
Third time’s the charm? Setterwalls has once again successfully represented pharmaceutical companies in defending itself against preliminary injunctions
News | 06 Sep 2023

Third time’s the charm? Setterwalls has once again successfully represented pharmaceutical companies in defending itself against preliminary injunctions

Läs nyhet
Setterwalls has successfully represented a client in a case of invalidation of a patent on sleep medicine
News | 09 Mar 2023

Setterwalls has successfully represented a client in a case of invalidation of a patent on sleep medicine

Läs nyhet
Publication UPC: The Sedona Conference Framework for Analysis for the Efficient Resolution of Disputes before the Forthcoming European Unified Patent Court
News | 10 Jan 2023

Publication UPC: The Sedona Conference Framework for Analysis for the Efficient Resolution of Disputes before the Forthcoming European Unified Patent Court

Läs nyhet
ICLG Patents 2023: Practical cross-border insights into patent law
News | 11 Oct 2022

ICLG Patents 2023: Practical cross-border insights into patent law

Läs nyhet
UPC opens its doors from 1 April 2023
News | 10 Oct 2022

UPC opens its doors from 1 April 2023

Läs nyhet
The new European patent system
News | 23 May 2022

The new European patent system

Läs nyhet
Single procedure for the granting of SPCs
News | 23 May 2022

Single procedure for the granting of SPCs

Läs nyhet
UP/UPC Update: The UPC Agreement may enter into force already in the autumn of 2022
News | 20 Jan 2022

UP/UPC Update: The UPC Agreement may enter into force already in the autumn of 2022

Läs nyhet
ICLG: Patent Law and Regulations 2022. Setterwalls’ experts explain Swedish patent law in the latest edition.
News | 22 Sep 2021

ICLG: Patent Law and Regulations 2022. Setterwalls’ experts explain Swedish patent law in the latest edition.

Läs nyhet
UP/UPC Update: Preliminary injunctions against the German UPCA ratification bill rejected – one step closer to the UPC
News | 14 Jul 2021

UP/UPC Update: Preliminary injunctions against the German UPCA ratification bill rejected – one step closer to the UPC

Läs nyhet
New Swedish ruling shows that strict liability (still) applies for losses caused by a preliminary injunction
News | 24 May 2021

New Swedish ruling shows that strict liability (still) applies for losses caused by a preliminary injunction

Läs nyhet
"Launch at risk” does not exclude a right to indemnification for losses suffered from a preliminary injunction
News | 07 May 2021

"Launch at risk” does not exclude a right to indemnification for losses suffered from a preliminary injunction

Läs nyhet
AI: turning yesterday’s science fiction into today’s reality – a challenge to the intellectual property rights framework?
News | 23 Mar 2021

AI: turning yesterday’s science fiction into today’s reality – a challenge to the intellectual property rights framework?

Läs nyhet
UP/UPC Update: German UPCA ratification put on hold
News | 14 Jan 2021

UP/UPC Update: German UPCA ratification put on hold

Läs nyhet
UP/UPC Update: Two constitutional complaints filed against the German UPCA ratification bill
News | 04 Jan 2021

UP/UPC Update: Two constitutional complaints filed against the German UPCA ratification bill

Läs nyhet
UP/UPC Update: The German Bundestag approves ratification bill for the UPCA
News | 30 Nov 2020

UP/UPC Update: The German Bundestag approves ratification bill for the UPCA

Läs nyhet
Setterwalls' experts explain patent litigation law in Sweden in this years’ edition of ICLG: Patents 2021
News | 24 Sep 2020

Setterwalls' experts explain patent litigation law in Sweden in this years’ edition of ICLG: Patents 2021

Läs nyhet
UP/UPC Update: The UPC Preparatory Committee signals a functional UPC in a near future
News | 18 Sep 2020

UP/UPC Update: The UPC Preparatory Committee signals a functional UPC in a near future

Läs nyhet
UP/UPC Update: Germany presents new draft ratification bill for the UPCA
News | 22 Jun 2020

UP/UPC Update: Germany presents new draft ratification bill for the UPCA

Läs nyhet
UP/UPC Update: The German government signals continued support and preparations for the Unitary Patent System
News | 30 Mar 2020

UP/UPC Update: The German government signals continued support and preparations for the Unitary Patent System

Läs nyhet
Clinical trials during a pandemic – COVID-19 and its impact on clinical trials
News | 27 Mar 2020

Clinical trials during a pandemic – COVID-19 and its impact on clinical trials

Läs nyhet
Setterwalls' experts explain patent litigation law in Sweden
News | 07 Oct 2019

Setterwalls' experts explain patent litigation law in Sweden

Läs nyhet
SPC Waiver published and enters into force on 1 July 2019
News | 12 Jun 2019

SPC Waiver published and enters into force on 1 July 2019

Läs nyhet
UP/UPC Update: Recruitment of judges reopens
News | 29 May 2019

UP/UPC Update: Recruitment of judges reopens

Läs nyhet
UP/UPC Update: Premises of the Paris seat of the Court of First Instance are displayed
News | 24 May 2019

UP/UPC Update: Premises of the Paris seat of the Court of First Instance are displayed

Läs nyhet
SPC Waiver adopted by the EU’s Council of Ministers
News | 15 May 2019

SPC Waiver adopted by the EU’s Council of Ministers

Läs nyhet
SPC Waiver approved by the European Parliament
News | 18 Apr 2019

SPC Waiver approved by the European Parliament

Läs nyhet
The SPC Waiver: Will a manufacturing exemption be approved next week?
News | 09 Apr 2019

The SPC Waiver: Will a manufacturing exemption be approved next week?

Läs nyhet
Setterwalls' experts explain the basics of litigating and commercializing patents in Sweden
News | 23 Aug 2018

Setterwalls' experts explain the basics of litigating and commercializing patents in Sweden

Läs nyhet
Striking a fair balance between indication patents and skinny-labelled drugs
News | 22 May 2018

Striking a fair balance between indication patents and skinny-labelled drugs

Läs nyhet
Are you personally liable for your company’s IP infringement? – the Swedish Patent and Market Court rules on IP infringement and lifting the corporate veil
News | 21 Nov 2017

Are you personally liable for your company’s IP infringement? – the Swedish Patent and Market Court rules on IP infringement and lifting the corporate veil

Läs nyhet
Restrictions of off-label use – an antitrust violation?
News | 06 Nov 2017

Restrictions of off-label use – an antitrust violation?

Läs nyhet
The Swedish Supreme Court takes a stance in the calculation of damages for a wrongful preliminary injunction
News | 17 May 2017

The Swedish Supreme Court takes a stance in the calculation of damages for a wrongful preliminary injunction

Läs nyhet
The New Clinical Trials Regulation
News | 17 May 2017

The New Clinical Trials Regulation

Läs nyhet
Kan överprissättning av läkemedel vara olaglig?
News | 17 May 2017

Kan överprissättning av läkemedel vara olaglig?

Läs nyhet
Life Sciences Report November 2015
News | 25 Nov 2015

Life Sciences Report November 2015

Läs nyhet
New procurement rules – Noted novelties
News | 01 Nov 2015

New procurement rules – Noted novelties

Läs nyhet
Life Sciences Report November 2014
News | 28 Nov 2014

Life Sciences Report November 2014

Läs nyhet
Medicinal products in Sweden: even more substitution?
News | 01 Nov 2014

Medicinal products in Sweden: even more substitution?

Läs nyhet